AJJ × Huaxi HIT-1 Humanoid Eldercare Robot Platform
Institutional, Commercial, Technical, Compliance and Governance Q&A
For Government Agencies, Eldercare Institutions, Data Engineers, Healthcare Compliance Officers and Procurement Committees
Important Notice / Public Communication Statement for a Listed Company
This Q&A has been prepared by AJJ Research as a public-facing explanatory and governance-support document for institutional, commercial, technical, compliance and procurement communication relating to the AJJ × Huaxi HIT-1 humanoid eldercare robot platform. It is intended to help investors, institutional customers and other stakeholders understand the product positioning, functional boundaries, deployment logic and compliance controls. This Q&A does not constitute legal advice, medical advice, clinical validation, HSA approval, independent technical certification or procurement advice. It also does not in itself constitute an announcement of a new material contract, revenue recognition, profit forecast, financial commitment, regulatory approval or any guarantee of commercial, financial or operational outcomes. Statements regarding product functions, system-integration capability, deployment pathways, KPI / ROI calculations, maintenance arrangements or regulatory positioning are provided for explanation only and should not be interpreted as commitments by the Company regarding revenue realisation, cost savings, manpower reduction, clinical outcomes, deployment approval or regulatory permissions beyond the scope of the Company’s publicly disclosed information. The Company will make further announcements as required under the applicable listing rules if there are any material commercial developments. Any actual deployment, procurement, system integration, pilot, scale-up, data processing or on-site use remains subject to contractual arrangements, site assessment, internal approval, user training, institutional SOPs, PDPA and other applicable compliance requirements and, where necessary, further HSA or other regulatory review.
Governance, Data Protection and Disclosure-Control Statement
This Q&A is intended for public communication by a Singapore-listed company and has been prepared under governance, data-protection and disclosure-control discipline. No personally identifiable resident data, confidential patient records, site-specific institution data, source code, confidential interface specifications, security credentials or non-public technical parameters are intended to be disclosed in this document. Any architecture, interface, workflow, alerting, audit, KPI or pricing references are high-level explanatory descriptions only and should not be treated as a full engineering specification, clinical protocol or legally binding operating standard. HIT-1 should be understood as a human-supervised care-support and eldercare operations platform with robotic front-end capabilities; it is not represented here as an autonomous medical diagnostic system, independent clinical decision-maker or substitute for licensed healthcare or caregiving personnel. Public statements regarding HSA notification, intended-use scope, AI outputs, monitoring functions and deployment scenarios must remain within the boundaries of the Company’s publicly disclosed information and applicable regulatory requirements. More detailed technical, compliance or integration materials should be shared only on an authorised need-to-know basis and, where appropriate, subject to confidentiality controls.
Document Type: Public-Facing Q&A and Governance Support
Document Prepared by: AJJ Research
Prepared for: Public communication, institutional review and stakeholder education
Disclosure Status: For SGX announcement support and public reference Version: Final Public-Facing Version Date: 8 July 2026